[Frontiers in Bioscience 11, 804-817, January 1, 2006] 804 Viral Vectors for Cancer Immunotherapy
نویسندگان
چکیده
1. Abstract 2. Introduction 2.1. History and successes of cancer immunotherapy 2.2. Viruses and cancer therapy 3. Identification of tumor associated antigens 4. Ideal properties of an antigen delivery system 4.1. Why are viral vectors suitable for delivering TAAs? 5. Poxvirus vectors 5.1. Vaccinia virus 5.1.1. Use of vaccinia viral vectors to deliver tumor antigens 5.1.1.1. Carcinoembryonic antigen (CEA) 5.1.1.2. Prostate specific antigen (PSA) 5.1.1.3. MUC-1 5.1.1.4. 5T4 5.2. Avian Poxviruses 5.2.1. Fowlpox 5.2.2. Canarypox 6. Adenovirus 7. Alphaviruses (Semliki forest, Sindbis, Venezuelan) 7.1. Semliki Forest Virus (SFV) 7.2. Sindbis virus (SIN) 7.3. Venezuelan equine encephalitis virus (VEE) 8. Miscellaneous viral vectors 8.1. Herpes simplex virus (HSV) 8.2. Newcastle Disease Virus (NDV) 9. Heterologous prime boost approaches 10. Perspective: The future of viral vectors for cancer immunotherapy and their potential limitations 11. Acknowledgments 12. References
منابع مشابه
[Frontiers in Bioscience 12, 2507-2518, January 1, 2007] 2507 Gene therapy in cutaneous wound healing
1. Abstract 2. Introduction 3. Viral vectors 3.1. Adenoviral vectors 3.2. Adeno-associatedvectors 3.3. Retroand Lentiviral vectors 3.4. Herpes viral vectors 4. Chemical gene transfer 5. Physical methods for gene delivery 5.1. Ballistic gene delivery 5.2. Micorseeding 5.3. Electroporation 6. Gene regulation 7. Gene silencing and transcriptional factors 8. Clinical trials 9. Perspective 10. Refer...
متن کاملImmuno-gene therapy approaches for cancer: from in vitro studies to clinical trials.
Immunotherapy against cancer basically aims at either broadly stimulating the immune system or at engineering an immune response against a targeted tumor associated antigen (TAA). In this review, we focus on the translation of immuno-gene therapy strategies into clinical trials for various cancers. Rather than being an exhaustive compendium of the literature, the focus of this article is to und...
متن کاملImmunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.
The utility of recombinant Sendai virus (rSeV) has been considerably examined over the last decade as a potent gene transfer candidate in a cytoplasmic gene expression system. Such risks as excessive immune responses associated with this virus administration in vivo however have limited its applicability in clinical settings as is the case with other viral vectors including adenoviruses. In con...
متن کاملTargeted, non-viral gene delivery for cancer gene therapy.
The ability to mediate targeted and specific delivery of therapeutics to cancer cells remains one of the most important hurdles in effectively treating cancer. This aspect also remains as one of the greatest limitations of gene therapy as well. Targeted vectors based on the use of DNA-binding agents attached to cell specific ligands or "molecular conjugates" were created with the goal of over-c...
متن کاملHVJ-based non-viral gene transfer method: successful gene therapy using HGF and VEGF genes in experimental ischemia.
VEGF and HGF are pleiotropic factors that regulate cell growth, cell motility, and morphogenesis of various types of cells. The receptors of these growth factors are expressed in neurons and endothelial cells, and are identified as neurotrophic, neuroprotective, and angiogenic factors. Indeed, gene therapy using viral vectors encoding the VEGF or HGF gene has been reported to be effective for p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2005